212 related articles for article (PubMed ID: 22436967)
1. Cardiovascular implantable electronic device endocarditis treated with daptomycin with or without transvenous removal.
Tascini C; Bongiorni MG; Di Cori A; Di Paolo A; Polidori M; Tagliaferri E; Fondelli S; Soldati E; Ciullo I; Leonildi A; Danesi R; Coluccia G; Menichetti F
Heart Lung; 2012; 41(6):e24-30. PubMed ID: 22436967
[TBL] [Abstract][Full Text] [Related]
2. High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis.
Durante-Mangoni E; Casillo R; Bernardo M; Caianiello C; Mattucci I; Pinto D; Agrusta F; Caprioli R; Albisinni R; Ragone E; Utili R
Clin Infect Dis; 2012 Feb; 54(3):347-54. PubMed ID: 22100575
[TBL] [Abstract][Full Text] [Related]
3. Microbiologic characteristics and in vitro susceptibility to antimicrobials in a large population of patients with cardiovascular implantable electronic device infection.
Jan E; Camou F; Texier-Maugein J; Whinnett Z; Caubet O; Ploux S; Pellegrin JL; Ritter P; Metayer PL; Roudaut R; Haissaguerre M; Bordachar P
J Cardiovasc Electrophysiol; 2012 Apr; 23(4):375-81. PubMed ID: 22082221
[TBL] [Abstract][Full Text] [Related]
4. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
Mohan SS; McDermott BP; Cunha BA
Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736
[TBL] [Abstract][Full Text] [Related]
5. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.
Fowler VG; Boucher HW; Corey GR; Abrutyn E; Karchmer AW; Rupp ME; Levine DP; Chambers HF; Tally FP; Vigliani GA; Cabell CH; Link AS; DeMeyer I; Filler SG; Zervos M; Cook P; Parsonnet J; Bernstein JM; Price CS; Forrest GN; Fätkenheuer G; Gareca M; Rehm SJ; Brodt HR; Tice A; Cosgrove SE;
N Engl J Med; 2006 Aug; 355(7):653-65. PubMed ID: 16914701
[TBL] [Abstract][Full Text] [Related]
6. Daptomycin cure after cefazolin treatment failure of Methicillin-sensitive Staphylococcus aureus (MSSA) tricuspid valve acute bacterial endocarditis from a peripherally inserted central catheter (PICC) line.
Cunha BA; Hamid N; Kessler H; Parchuri S
Heart Lung; 2005; 34(6):442-7. PubMed ID: 16324966
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular implantable electronic device infection in patients with Staphylococcus aureus bacteremia.
Uslan DZ; Dowsley TF; Sohail MR; Hayes DL; Friedman PA; Wilson WR; Steckelberg JM; Baddour LM
Pacing Clin Electrophysiol; 2010 Apr; 33(4):407-13. PubMed ID: 19793360
[TBL] [Abstract][Full Text] [Related]
8. Methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE) in a patient with Job's syndrome (hyperimmunoglobulin E syndrome) successfully treated with linezolid and high-dose daptomycin.
Cunha BA; Krol V; Kodali V
Heart Lung; 2008; 37(1):72-5. PubMed ID: 18206530
[TBL] [Abstract][Full Text] [Related]
9. Cardiac device-related endocarditis complicated by spinal abscess.
Rodriguez Y; Greenspon AJ; Sohail MR; Carrillo RG
Pacing Clin Electrophysiol; 2012 Mar; 35(3):269-74. PubMed ID: 22150338
[TBL] [Abstract][Full Text] [Related]
10. Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study.
Moore CL; Osaki-Kiyan P; Haque NZ; Perri MB; Donabedian S; Zervos MJ
Clin Infect Dis; 2012 Jan; 54(1):51-8. PubMed ID: 22109947
[TBL] [Abstract][Full Text] [Related]
11. Successful salvage therapy with daptomycin after linezolid and vancomycin failure in a liver transplant recipient with methicillin-resistant Staphylococcus aureus endocarditis.
Vernadakis S; Saner FH; Rath PM; Kaiser GM; Mathe Z; Treckmann J; Paul A
Transpl Infect Dis; 2009 Aug; 11(4):346-8. PubMed ID: 19497075
[TBL] [Abstract][Full Text] [Related]
12. Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: a retrospective cohort study utilizing the Cubicin Outcomes Registry and Experience.
Sakoulas G; Brown J; Lamp KC; Friedrich LV; Lindfield KC
Clin Ther; 2009 Sep; 31(9):1936-45. PubMed ID: 19843483
[TBL] [Abstract][Full Text] [Related]
13. Retrospective case-control analysis of patients with staphylococcal infections receiving daptomycin or glycopeptide therapy.
Falcone M; Russo A; Pompeo ME; Vena A; Marruncheddu L; Ciccaglioni A; Grossi P; Mancini C; Novelli A; Stefani S; Venditti M
Int J Antimicrob Agents; 2012 Jan; 39(1):64-8. PubMed ID: 22047703
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of ceftobiprole, daptomycin, linezolid, and vancomycin against methicillin-resistant staphylococci associated with endocarditis and bone and joint infection.
Rouse MS; Steckelberg JM; Patel R
Diagn Microbiol Infect Dis; 2007 Jul; 58(3):363-5. PubMed ID: 17449212
[TBL] [Abstract][Full Text] [Related]
15. Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients.
Segreti JA; Crank CW; Finney MS
Pharmacotherapy; 2006 Mar; 26(3):347-52. PubMed ID: 16503714
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness of daptomycin versus vancomycin and gentamicin for patients with methicillin-resistant Staphylococcus aureus bacteremia and/or endocarditis.
Bhavnani SM; Prakhya A; Hammel JP; Ambrose PG
Clin Infect Dis; 2009 Sep; 49(5):691-8. PubMed ID: 19635023
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of mitral MRSA endocarditis using daptomycin].
Senneville E; Beltrand E; Legout L; Leroy O; Fayad G
Med Mal Infect; 2008 Dec; 38 Spec No 2():13-5. PubMed ID: 19185204
[No Abstract] [Full Text] [Related]
18. Development of multiple lung abscesses during daptomycin treatment for right-sided endocarditis caused by meticillin-resistant Staphylococcus aureus.
Liu CY; Wang JL; Huang YT; Hsueh PR
Int J Antimicrob Agents; 2008 Dec; 32(6):544-5. PubMed ID: 18789850
[No Abstract] [Full Text] [Related]
19. Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure.
Joson J; Grover C; Downer C; Pujar T; Heidari A
J Antimicrob Chemother; 2011 Sep; 66(9):2186-8. PubMed ID: 21653600
[No Abstract] [Full Text] [Related]
20. Efficacy of daptomycin in complicated skin and skin-structure infections due to methicillin-sensitive and -resistant Staphylococcus aureus: results from the CORE Registry.
Martone WJ; Lamp KC
Curr Med Res Opin; 2006 Dec; 22(12):2337-43. PubMed ID: 17257448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]